Namrata K Taak

  • Citations Per Year
Learn More
BACKGROUND/AIMS The histological and clinical outcome of lamivudine 100mg/day was assessed in 76 HBeAg-negative chronic hepatitis B patients previously randomised to a double-blind comparison study of lamivudine and placebo. METHODS Paired liver biopsies were available before 1 year of randomised lamivudine treatment and after 2 years of further(More)
  • 1